IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Domenico Mallardo Ester Simeone Lucia Festino Marilena Tuffanelli Vito Vanella Claudia Trojaniello Maria Grazia Vitale Margaret Ottaviano Mariaelena Capone Gabriele MadonnaFrancesca SparanoEleonora Cioli Luigi Scarpato Marco Palla Rossella Di Trolio Paolo Meinardi Corrado CaracòGerardo FerraraPaolo Muto Ernesta Cavalcanti Paolo Antonio Ascierto

Published in: Journal of translational medicine (2023)

Serum levels of IL-6 at baseline and changes after cemiplimab immunotherapy may have a prognostic significance in patients with advanced cutaneous squamous cell carcinoma.

Keyphrases

squamous cell carcinoma
prognostic factors
lymph node metastasis
locally advanced
radiation therapy